Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
---|---|---|---|---|---|---|---|---|
ASPS16 | Patient Safety | Airway Assessment for patients undergoing Rhinoplasty | Process | Registry | Details | |||
ASPS10 | Person and Caregiver Centered Experience and Outcomes | Patient Satisfaction with Information Provided during Breast Reconstruction | Outcome | Registry | Details | |||
ASNC29 | Communication and Care Coordination | SPECT and PET MPI study documentation of stress perfusion defects | Process | Registry | Details | |||
ASNC28 | Patient Safety | SPECT-MPI effective dose less than or equal to 9 millisieverts as per ASNC guideline recommendations | Outcome | Registry | Details | |||
ASNC23 | Efficiency and Cost Reduction | SPECT-MPI study clinical utilization of Attenuation Correction image acquisition | Process | Registry | Details | |||
ASNC19 | Patient Safety | Imaging Protocols for SPECT and PET MPI studies - Use of stress only protocol | Outcome | Registry | Details | |||
AQUA8 | Effective Clinical Care | Hospital admissions/complications within 30 days of TRUS Biopsy | Outcome | Registry | Details | |||
AQUA32 | Effective Clinical Care | Hypogonadism: Laboratory evaluation conducted within 6 months of starting testosterone replacement | Process | Registry | Details | |||
AQUA26 | Efficiency and Cost Reduction | Benign Prostate Hyperplasia Care: Benign Prostate Hyperplasia | Process | Registry | Details | |||
AQUA24 | Effective Clinical Care | Testosterone and PSA levels checked for CRPC patients | Process | Registry | Details | |||
AQUA22 | Effective Clinical Care | Bone imaging and soft tissue imaging within 30 days (before or after) of diagnosis of metastatic CRPC | Process | Registry | Details | |||
AQUA21 | Effective Clinical Care | Appropriate Management of Obstructive Azoospermia | Process | Registry | Details | |||
AQUA19 | Effective Clinical Care | Diagnosis of Type of Azoospermia and Diagnostic Testing for Obstructive Azoospermia | Process | Registry | Details | |||
AQUA18 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Early surveillance cystoscopy within 4 months of initial diagnosis | Process | Registry | Details | |||
AQUA17 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Initiation of BCG within 3 months of diagnosis of high-grade T1 bladder cancer and/or CIS | Process | Registry | Details | |||
AQUA16 | Effective Clinical Care | Non-Muscle Invasive Bladder Cancer: Repeat Transurethral Resection of Bladder Tumor (TURBT) for T1 disease | Process | Registry | Details | |||
AQUA15 | Patient Safety | Stones: Urinalysis documented 30 days before surgical stone procedures | Process | Registry | Details | |||
AQUA14 | Effective Clinical Care | Stones: Repeat Shock Wave Lithotripsy (SWL) within 6 months of treatment | Outcome | Registry | Details | |||
AQI68 | Patient Safety | Obstructive Sleep Apnea: Mitigation Strategies | Process | Registry | Details | |||
AQI67 | Communication and Care Coordination | Consultation for Frail Patients | Process | Registry | Details |